BMS names Giovanni Caforio COO
This article was originally published in Scrip
Bristol-Myers Squibb has promoted Dr Giovanni Caforio to chief operating officer and a member of its board of directors, effective from 5 June 2014. He will continue to report to Lamberto Andreotti, chief executive officer of the company. Previously, Dr Caforio was US president and chief commercial officer at BMS from 2011 to 2014. He originally joined the New York-based drugmaker in in 2000 as vice-president and general manager, Italy.